Registro:

Referencias:

• Andrews, D.W., Resnicoff, M., Flanders, A.E., Kenyon, L., Curtis, M., Merli, G., Baserga, R., Aiken, R.D., Results of a pilot study involving the use of an antisense oligodeoxynucleotide directed against the insulin-like growth factor type I receptor in malignant astrocytomas (2001) Journal of Clinical Oncology, 19, pp. 2189-2200
• Bairey, O., Zimra, Y., Shaklai, M., Rabizadeh, E., Bcl-2 expression correlates positively with serum basic fibroblast growth factor (bFGF) and negatively with cellular vascular endothelial growth factor (VEGF) in patients with chronic lymphocytic leukaemia (2001) British Journal of Haematology, 113, pp. 400-406
• Baserga, R., The IGF-I receptor in cancer research (1999) Experimental Cell Research, 253, pp. 1-6
• Baserga, R., Hongo, A., Rubini, M., Frisco, M., Valentinis, B., The IGF-I receptor in cell growth, transformation and apoptosis (1997) Biochimica et Biophysica Acta, 1332, pp. F105-F126
• Breier, B.H., Gallaher, B.W., Gluckman, P.D., Radioimmunoassay for insulin-like growth factor-I: Solutions to some potential problems and pitfalls (1991) Journal of Endocrinology, 128, pp. 347-357
• Brocardo, M.G., Schillaci, R., Galeano, A., Radrizzani, M., White, V., Guerrico, A.G., Santa-Coloma, T.A., Roldan, A., Early effects of insulin-like growth factor-1 in activated human T lymphocytes (2001) Journal of Leukocyte Biology, 70, pp. 297-305
• Chan, J.M., Stampfer, M.J., Giovannucci, E., Gann, P.H., Ma, J., Wilkinson, P., Hennekens, C.H., Pollak, M., Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study (1998) Science, 279, pp. 563-566
• Cheson, B.D., Bennett, J.M., Grever, M., Kay, N., Keating, M.J., O'Brien, S., Rai, K.R., National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukaemia: Revised guidelines for diagnosis and treatment (1996) Blood, 87, pp. 4990-4997
• Del Poeta, G., Maurillo, L., Venditti, A., Buccisano, F., Epiceno, A.M., Capelli, G., Tamburini, A., Amadori, S., Clinical significance of CD38 expression in chronic lymphocytic leukemia (2001) Blood, 98, pp. 2633-2639
• Gottardi, D., Alfarano, A., De Leo, A.M., Stacchini, A., Aragno, M., Rigo, A., Veneri, D., Caligaris-Cappio, F., In leukaemic CD5+ B cells the expression of BCL-2 gene family is shifted toward protection from apoptosis (1996) British Journal of Haematology, 94, pp. 612-618
• Grimberg, A., Cohen, P., Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis (2000) Journal of Cellular Physiology, 183, pp. 1-9
• Hanada, M., Delia, D., Aiello, A., Stadtmauer, E., Reed, J.C., bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia (1993) Blood, 82, pp. 1820-1828
• Hankinson, S.E., Willett, W.C., Colditz, G.A., Hunter, D.J., Michaud, D.S., Deroo, B., Rosner, B., Pollak, M., Circulating concentrations of insulin-like growth factor-I and risk of breast cancer (1998) Lancet, 351, pp. 1393-1396
• Harris, N.L., Jaffe, E.S., Stein, H., Banks, P.M., Chan, J.K., Cleary, M.L., Delsol, G., Gatter, K.C., A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group (1994) Blood, 84, pp. 1361-1392
• Jansen, E., Steenbergh, P.H., Leroith, D., Roberts Jr., C.T., Sussenbach, J.S., Identification of multiple transcription start sites in the human insulin-like growth factor-I gene (1991) Molecular and Cellular Endocrinology, 78, pp. 115-125
• Klasa, R.J., Gillum, A.M., Klem, R.E., Frankel, S.R., Oblimersen Bcl-2 antisense: Facilitating apoptosis in anticancer treatment (2002) Antisense and Nucleic Acid Drug Development, 12, pp. 193-213
• Kooijman, R., Willems, M., De Haas, C.J., Rijkers, G.T., Schuurmans, A.L., Buul-Offers, S.C., Heijnen, C.J., Zegers, B.J., Expression of type I insulin-like growth factor receptors on human peripheral blood mononuclear cells (1992) Endocrinology, 131, pp. 2244-2250
• Lacau-Mengido, I.M., Mejia, M.E., Diaz-Torga, G.S., Gonzalez, I.A., Formia, N., Libertun, C., Becu-Villalobos, D., Endocrine studies in ivermectin-treated heifers from birth to puberty (2000) Journal of Animal Science, 78, pp. 817-824
• Landreth, K.S., Narayanan, R., Dorshkind, K., Insulin-like growth factor-I regulates pro-B cell differentiation (1992) Blood, 80, pp. 1207-1212
• Lowe Jr., W.L., Lasky, S.R., Leroith, D., Roberts Jr., C.T., Distribution and regulation of rat insulin-like growth factor I messenger ribonucleic acids encoding alternative carboxyterminal E-peptides: Evidence for differential processing and regulation in liver (1988) Molecular Endocrinology, 2, pp. 528-535
• Lydyard, P.M., Jewell, A.P., Jamin, C., Youinou, P.Y., CDS B cells and B-cell malignancies (1999) Current Opinion in Hematology, 6, pp. 30-36
• Merimee, T.J., Grant, M.B., Broder, C.M., Cavalli-Sforza, L.L., Insulin-like growth factor secretion by human B-lymphocytes: A comparison of cells from normal and pygmy subjects (1989) Journal of Clinical Endocrinology and Metabolism, 69, pp. 978-984
• Minshall, C., Arkins, S., Straza, J., Conners, J., Dantzer, R., Freund, G.G., Kelley, K.W., IL-4 and insulin-like growth factor-I inhibit the decline in Bcl-2 and promote the survival of IL-3-deprived myeloid progenitors (1997) Journal of Immunology, 159, pp. 1225-1232
• Mitsiades, C.S., Mitsiades, N.S., McMullan, C.J., Poulaki, V., Shringarpure, R., Akiyama, M., Hideshima, T., Kung, A.L., Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors (2004) Cancer Cell, 5, pp. 221-230
• O'Connor, R., Kauffmann-Zeh, A., Liu, Y., Lehar, S., Evan, G.I., Baserga, R., Blattler, W.A., Identification of domains of the insulin-like growth factor I receptor that are required for protection from apoptosis (1997) Molecular and Cellular Biology, 17, pp. 427-435
• Pepper, C., Thomas, A., Hoy, T., Bentley, P., Chlorambucil resistance in B-cell chronic lymphocytic leukaemia is mediated through failed Bax induction and selection of high Bcl-2-expressing subclones (1999) British Journal of Haematology, 104, pp. 581-588
• Quinn, K.A., Treston, A.M., Unsworth, E.J., Miller, M.J., Vos, M., Grimley, C., Battey, J., Cuttitta, F., Insulin-like growth factor expression in human cancer cell lines (1996) Journal of Biological Chemistry, 271, pp. 11477-11483
• Ratajczak, M.Z., Kuczynski, W.I., Onodera, K., Moore, J., Ratajczak, J., Kregenow, D.A., Deriel, K., Gewirtz, A.M., A reappraisal of the role of insulin-like growth factor I in the regulation of human hematopoiesis (1994) Journal of Clinical Investigation, 94, pp. 320-327
• Reed, J.C., Bcl-2: Prevention of apoptosis as a mechanism of drug resistance (1995) Hematology/Oncology Clinics of North America, 9, pp. 451-473
• Rodriguez-Tarduchy, G., Collins, M.K., Garcia, I., Lopez-Rivas, A., Insulin-like growth factor-I inhibits apoptosis in IL-3-dependent hemopoietic cells (1992) Journal of Immunology, 149, pp. 535-540
• Rohlik, Q.T., Adams, D., Kull Jr., F.C., Jacobs, S., An antibody to the receptor for insulin-like growth factor I inhibits the growth of MCF-7 cells in tissue culture (1987) Biochemical and Biophysical Research Communications, 149, pp. 276-281
• Salatino, M., Schillaci, R., Proietti, C.J., Carnevale, R., Frahm, I., Molinolo, A.A., Iribarren, A., Elizalde, P.V., Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity (2004) Oncogene, 23, pp. 5161-5174
• Schillaci, R., Ribaudo, C.M., Rondinone, C.M., Roldan, A., Role of insulin-like growth factor-1 on the kinetics of human lymphocytes stimulation in serum-free culture medium (1994) Immunology and Cell Biology, 72, pp. 300-305
• Schillaci, R., Brocardo, M.G., Galeano, A., Roldan, A., Downregulation of insulin-like growth factor-1 receptor (IGF-1R) expression in human T lymphocyte activation (1998) Cellular Immunology, 183, pp. 157-161
• Segretin, M.E., Galeano, A., Roldan, A., Schillaci, R., Insulin-like growth factor-1 receptor regulation in activated human T lymphocytes (2003) Hormone Research, 59, pp. 276-280
• Stewart, C.E., Rotwein, P., Growth, differentiation, and survival: Multiple physiological functions for insulin-like growth factors (1996) Physiological Reviews, 76, pp. 1005-1026
• Swolin, D., Brantsing, C., Matejka, G., Ohlsson, C., Cortisol decreases IGF-I mRNA levels in human osteoblast-like cells (1996) Journal of Endocrinology, 149, pp. 397-403
• Wang, L.M., Myers Jr., M.G., Sun, X.J., Aaronson, S.A., White, M., Pierce, J.H., IRS-1: Essential for insulin- and IL-4-stimulated mitogenesis in hematopoietic cells (1993) Science, 261, pp. 1591-1594
• Werner, H., Leroith, D., The role of the insulin-like growth factor system in human cancer (1996) Advances in Cancer Research, 68, pp. 183-223
• Yakar, S., Liu, J.L., Stannard, B., Butler, A., Accili, D., Sauer, B., Leroith, D., Normal growth and development in the absence of hepatic insulin-like growth factor I (1999) Proceedings of the National Academy of Sciences of the United States of America, 96, pp. 7324-7329
• Zapf, J., Walter, H., Froesch, E.R., Radioimmunological determination of insulin-like growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycemia (1981) Journal of Clinical Investigation, 68, pp. 1321-1330
• Zhou, L., Ritchie, D., Wang, E.Y., Barbone, A.G., Argentieri, D., Lau, C.Y., Tepoxalin, a novel immunosuppressive agent with a different mechanism of action from cyclosporin a (1994) Journal of Immunology, 153, pp. 5026-5037

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------